| Ms Martha L Ketteridge, NP | |
|
210 E Main St, Ste 5, Huntington, NY 11743-2979 | |
| (631) 864-1795 | |
| (631) 864-1795 |
| Full Name | Ms Martha L Ketteridge |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 23 Years |
| Location | 210 E Main St, Huntington, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952488454 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0808X | Clinical Nurse Specialist - Psychiatric/mental Health | F400635 (New York) | Primary |
| 363L00000X | Nurse Practitioner | F400635 (Florida) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Martha L Ketteridge, NP 210 E Main St, Ste 5, Huntington, NY 11743-2979 Ph: (631) 864-1795 | Ms Martha L Ketteridge, NP 210 E Main St, Ste 5, Huntington, NY 11743-2979 Ph: (631) 864-1795 |
News Archive
Resverlogix Corp. announced today that key scientific data was communicated in an oral presentation highlighting the novel features of RVX-208, the Company's lead drug, during the Atherosclerosis, Thrombosis, Vascular Biology conference being held in San Francisco, California.
According to a study published in the August issue of the Journal of the American College of Surgeons, there was an increase in the number of laparoscopic bariatric procedures, an increase in the number of bariatric surgeons and a decrease of inhospital mortality rates between 2003 and 2008.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
The Women's Health Initiative Studies, a large prospective study of lung cancer, found no strong associations between lung cancer risk and a wide range of reproductive history variables and only revealed weak support for a role of hormone use in the incidence of lung cancer.
› Verified 9 days ago
Bohdan Hladun, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 10 Horizon Dr, Huntington, NY 11743 Phone: 347-279-8763 |